Recursion 5 juin 2026 Recursion Pharma director Christopher Gibson sells $144,800 in stock - Investing.com
Recursion 5 juin 2026 Recursion Pharma director Christopher Gibson sells $144,800 in stock - Investing.com
Recursion 4 juin 2026 Recursion Pharmaceuticals Stock (RXRX) Opinions on Clinical Proof and AI Platform Advancements - Quiver Quantitative
Recursion 4 juin 2026 Why Recursion Pharmaceuticals (RXRX) Is Up 9.5% After AI Pipeline Progress And Stronger-Than-Expected Q1 Results - Yahoo Finance
Recursion 2 juin 2026 Recursion vs. Schrodinger: Comparing Biotech and Software Drug Discovery Strategies in 2026 - News and Statistics - IndexBox
Recursion 2 juin 2026 A Look At Recursion Pharmaceuticals (RXRX) Valuation As Shares Show Short Term Momentum - simplywall.st
Recursion 2 juin 2026 Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026? - AOL.com
Recursion 25 mai 2026 Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now? - The Motley Fool
Recursion 21 mai 2026 Can Altitude Lab’s Early Wins Reframe Recursion Pharmaceuticals’ (RXRX) High-Burn Platform Bet? - Sahm
Recursion 20 mai 2026 Can Altitude Lab’s Early Wins Reframe Recursion Pharmaceuticals’ (RXRX) High-Burn Platform Bet? - simplywall.st
Recursion 10 mai 2026 A Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates - simplywall.st
Recursion 9 mai 2026 A Look At Recursion Pharmaceuticals (RXRX) Valuation After Clinical Updates And FDA Discussions - Yahoo Finance
Recursion 8 mai 2026 Recursion Milestones Link AI Discovery To Clinical And Valuation Upside - Yahoo Finance
Recursion 8 mai 2026 Recursion’s AI Drug Programs Show Early Clinical Progress And Valuation Gap - simplywall.st
Recursion 6 mai 2026 After a decade of hype, Najat Khan is bringing Recursion back down to earth - Fierce Biotech
Recursion 6 mai 2026 Recursion Pharmaceuticals Stock (RXRX) Opinions on Q1 2026 Earnings - Quiver Quantitative
Recursion 6 mai 2026 Recursion Reports First Quarter Financial Results and Provides Business Update - markets.businessinsider.com